Cardiovascular Aging Research & Development (CARD) Symposium

The Cardiovascular Aging Research & Development (CARD) Symposium brings together leaders across biotechnology, medicine, and academia to discuss the next generation of cardiovascular therapeutics: from emerging clinical trials and precision cardiology to the molecular mechanisms driving cardiometabolic disease. We're excited to announce that John Maraganore (Founding CEO of Alnylam; Co-CEO of Corsera Health), Sekar Kathiresan (CEO of Verve Therapeutics; EVP at Eli Lilly), Michelle O'Donoghue (Brigham and Women's Hospital / TIMI Study Group), and Michael Davidson (CEO of NewAmsterdam Pharma) will be joining us as featured speakers at CARD. Scientific sessions will explore topics ranging from AI-driven cardiovascular data analysis and precision medicine to Lp(a)-targeted therapeutics, gene editing, cardiometabolic drug development, lipid biology, aldosterone dysregulation, vascular inflammation, and the translation of basic discoveries into new clinical therapies. Hosted by the Aging Initiative, CARD aims to bridge basic science, translational research, clinical medicine, and biotechnology to accelerate progress against cardiovascular disease, the world's leading cause of death. Registration approval is required to attend. Interested in sponsoring the symposium? Contact [email protected].